Zobrazeno 1 - 2
of 2
pro vyhledávání: '"B Rey-Rubio"'
Publikováno v:
Section 3: Production and Compounding.
Background In our medical centre, the production of injectable ant-ineoplastic rose 20% between 2015 and 2017. As a consequence, the dispensing delay increased. It has therefore been decided to implement dose-banding. In order to guarantee the steril
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1b2b79a1ef56484e3f678a68f4c0386
https://doi.org/10.1136/ejhpharm-2019-eahpconf.103
https://doi.org/10.1136/ejhpharm-2019-eahpconf.103
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background The development and expansion of oral anti-cancer agents provide multiple benefits, including improvement in patients’ quality of life but also create numerous challenges such as side-effect management or medication adherence. In January
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::779a0c6ea0a23c0b8d8ac36d8d05141b
https://doi.org/10.1136/ejhpharm-2019-eahpconf.408
https://doi.org/10.1136/ejhpharm-2019-eahpconf.408